Trials / Completed
CompletedNCT03133325
A Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine
A Randomized, Split Arm Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a study to assess the safety of GP0045 compared to Restylane Lyft Lidocaine. There is a 12-week follow-up period. AEs will be recorded throughout the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GP0045 | Hyaluronic acid gel |
| DEVICE | Restylane Lyft Lidocaine | Hyaluronic acid gel |
Timeline
- Start date
- 2017-04-19
- Primary completion
- 2017-07-13
- Completion
- 2017-07-13
- First posted
- 2017-04-28
- Last updated
- 2022-08-25
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT03133325. Inclusion in this directory is not an endorsement.